Avalyn Pharma Inc. (AVLN) Live Share Price, Invest From India

Avalyn Pharma Inc. Stock Performance

as on June 17, 2026 at 2:15 pm IST

Day's Low
Day's High
$28.01
Day's Price Range
$29.78
$28.07
0.21%
Downside
6.09%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$28.07
100.00%
Downside
-100.00%
Upside

Avalyn Pharma Inc. share price movements today

Previous Close: $28.75
Open: $28.26
Volume: 350.8K
Day's Low - High: $28.01 - $29.78

Avalyn Pharma Inc. Historical Returns

1 Month Return: -5.93 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Avalyn Pharma Inc. Stock Fundamentals & Key Indicators

Check Avalyn Pharma Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.3B

EPS (TTM)

-1.94

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-68.34%

Avalyn Pharma Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Avalyn Pharma Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Avalyn Pharma Inc.	NA	$1.3B	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$38.4B	63.66%	72.49	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$114.3B	140.59%	26.73	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$64.5B	14.69%	15.02	29.65%	0.58%

Avalyn Pharma Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2025	Mar 2026
Total Revenue	-	-
Gross Profit	-	-
Operating Income	-18	-27
EBITDA	-	-
Interest Expense	-	0
Depreciation	0	0
Income Before Tax	-17	-26
Income Tax Expense	-	-
Net Income	-17	-26
Net Profit Margin	0.00%	0.00%

Avalyn Pharma Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2024	Dec 2025
Total Revenue	-	-
Gross Profit	-	-
Operating Income	-57	-91
EBITDA	-	-
Interest Expense	-	-
Depreciation	0	0
Income Before Tax	-49	-85
Income Tax Expense	-	-
Net Income	-49	-85
Net Profit Margin	0.00%	0.00%

Avalyn Pharma Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2026
Net Income	-26
Operating Cash Flow	-29
Investing Cash Flow	-
Financing Cash Flow	14
Change in Cash	39

Avalyn Pharma Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2025
Net Income	-85
Operating Cash Flow	-81
Investing Cash Flow	-
Financing Cash Flow	99
Change in Cash	28

Avalyn Pharma Inc. News & Key Events

Insights on Avalyn Pharma Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, AVLN stock has moved down by -1.6%

About Avalyn Pharma Inc.

Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company provides inhaled formulations of oral medicines directly to the lungs. Its current pipeline is focused on treating pulmonary fibrosis. Its products include AP01 and AP02, inhaled formulations of pirfenidone and nintedanib for the treatment of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis; and AP03, a fixed-dose combination of inhaled pirfenidone and nintedanib to deliver dual antifibrotic mechanisms. Avalyn Pharma Inc. was formerly known as Genoa Pharmaceuticals, Inc. and changed its name to Avalyn Pharma Inc. in July 2017. The company was incorporated in 2011 and is based in Boston, Massachusetts.

Organisation	Avalyn Pharma Inc.
Headquarters	105 W First Street, Boston, MA, United States, 02127
Industry	Biotechnology
CEO	Ms. Lyn Baranowski
E-voting on shares	Click here to vote

Key Management of Avalyn Pharma Inc.

Name	Title
Ms. Cassie Saitow	Senior Director of IR & Corporate Communications
Mr. Adam H, Golden J.D.	General Counsel & Head of Business Development
Dr. Stephen Pham Ph.D.	Senior Vice President of Product Development
Ms. Lyn Baranowski	CEO, President & Director
Mr. Douglas R. Carlson	CFO & Chief Business Officer
Dr. Melissa Rhodes DABT, Ph.D.	Chief Operating Officer
Ms. Michelle Patterson M.B.A., P.M.P.	Senior Vice President of Corporate Planning & Portfolio Strategy
Dr. Howard M. Lazarus M.D.	Chief Medical Officer
Dr. Craig Conoscenti M.D.	Senior Vice President of Clinical Development
Mr. James Bishop	Senior Vice President of Business Operations

FAQs

What is Avalyn Pharma Inc. share price today?

Avalyn Pharma Inc. share price today is $28.07 as on June 17, 2026 at 8:45 am IST at the close of the market. Avalyn Pharma Inc. share today touched a day high of $29.78 and a low of $28.01.

What is the 52 week high and 52 week low for Avalyn Pharma Inc. share?

Avalyn Pharma Inc. share touched a 52 week high of $0 on January 1, 1970 and a 52 week low of $0 on January 1, 1970. Avalyn Pharma Inc. stock price today i.e. June 17, 2026 at 8:45 am IST is closed at $28.07,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Avalyn Pharma Inc.'s market capitalisation today?

Avalyn Pharma Inc. market capitalisation is $0.00T as on June 17, 2026 at 8:45 am IST.

How to invest in Avalyn Pharma Inc. Stock (AVLN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Avalyn Pharma Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Avalyn Pharma Inc. Shares that will get you 0.0534 shares as per Avalyn Pharma Inc. share price of $28.07 per share as on June 17, 2026 at 8:45 am IST.

What is the minimum amount required to buy Avalyn Pharma Inc. Stock (AVLN) from India?

Indian investors can start investing in Avalyn Pharma Inc. (AVLN) shares with as little as ₹94.55 or $1 (as of June 17, 2026 at 2:44 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹945.50 in Avalyn Pharma Inc. stock (as per the Rupee-Dollar exchange rate as on June 17, 2026 at 2:44 pm IST). Based on Avalyn Pharma Inc. share’s latest price of $28.07 as on June 17, 2026 at 8:45 am IST, you will get 0.3563 shares of Avalyn Pharma Inc.. Learn more about fractional shares .